SWOG clinical trial number
CTSU/EAQ221CD
Improving Medication Adherence in Breast Cancer Using a Connected Customized Treatment Platform (CONCURxP) SWOG Study Champion: Scott Ramsey, M.D., Ph.D. -
Open
Phase
Abbreviated Title
Improving Medication Adherence in Breast Cancer Using a Connected Customized Treatment Platform (CONCURxP)<br />SWOG Study Champion: Scott Ramsey, M.D., Ph.D.<br /><br />
Research committees
Cancer Care Delivery
Other Clinical Trials
SWOG Clinical Trial Number
S2417CD
A Pragmatic Randomized Controlled Trial to Evaluate the Effectiveness of an Intervention called Current Together After Cancer (CTAC) to Promote Guideline-Concordant Colorectal Cancer Surveillance
Research Committee(s)
Cancer Care Delivery
Gastrointestinal Cancer
Activated
08/04/2025
Accrual
2%
Open
Phase
SWOG Clinical Trial Number
S1703
Randomized trial comparing overall survival of patients monitored with serum tumor marker directed disease monitoring (STMDDM) versus usual care in patients with metastatic hormone receptor positive breast cancer
Research Committee(s)
Cancer Care Delivery
Breast Cancer
Activated
07/16/2018
Accrual
88%
Open
Phase
SWOG Clinical Trial Number
CTSU/EAQ221CD
Improving Medication Adherence in Breast Cancer Using a Connected Customized Treatment Platform (CONCURxP) SWOG Study Champion: Scott Ramsey, M.D., Ph.D. -
Research Committee(s)
Cancer Care Delivery
Open
Phase